DB15175InvestigationalGene Therapies
Ofranergene obadenovec is under investigation in clinical trial NCT01229865 (Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer).
- Also known as
- GENETIC VECTOR CONTAINING TUMOR VASCULAR ENDOTHELIUM-DIRECTED CHIMERIC FAS ANTIGEN GENE
- Code names
- VB-111
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Ofranergene obadenovec, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account